What is I Am Als?
I Am Als operates as a patient-led organization that integrates direct support, policy advocacy, and research advancement to address the complexities of ALS. By centering the experiences of those living with the disease, the organization bridges the gap between clinical research and patient needs. Its operational model provides essential resources, including peer mentoring and clinical trial navigation, while simultaneously mobilizing a community of advocates to influence health policy and research funding priorities. This dual-focus strategy ensures that the organization remains both a vital support network and a powerful force for systemic change in the medical landscape.
How much funding has I Am Als raised?
I Am Als has raised a total of $133K across 1 funding round:
Debt
$133K
Debt (2021): $133K with participation from PPP
Key Investors in I Am Als
PPP
Public-Private Partnership
What's next for I Am Als?
With this recent infusion of capital, I Am Als is poised to scale its advocacy efforts and expand its reach within the global ALS community. The organization will likely prioritize the enhancement of its digital support infrastructure and the deepening of its research partnerships to expedite the development of emerging therapeutic possibilities. By leveraging its unique position as a patient-led entity, I Am Als aims to further influence the trajectory of disease research, ensuring that patient insights remain at the forefront of medical innovation and policy decision-making processes.
See full I Am Als company page
